Circulating tumor DNA as part of the routine work-up for patients with suspected advanced lung cancer
{{output}}
Liquid biopsy (LB) is a useful tool in patients with advanced non-small cell lung cancer (aNSCLC) to detect actionable molecular alterations and thereby allow genotype-matched therapies. Currently, LB is recommended for individuals diagnosed with aNSCLC who ha... ...
